Industry

Actively enrolling patients with lupus nephritis (LN), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) in Phase 1 clinical trial of ADI-001 in autoimmune diseases On track to report preliminary clinical data for ADI-001 in 2H/2025 Enrollment now open for patients with idiopathic inflammatory myopathy (IIM), stiff person syndrome (SPS) and anti-neutrophil cytoplasmic autoantibody associated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Chondrosarcoma Market – A Global and Regional Analysis: Focus on Type, Treatment Type, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. Chondrosarcoma is a rare malignant tumor of cartilage-forming tissue, most commonly affecting bones such as the pelvis, femur, and humerus. Subtypes include conventional, dedifferentiated, mesenchymal, and … [Read more…]

Community Event to Support People with Breast Cancer, Raise Funds for Research and Advocacy Takes Place September 13, 2025 DETROIT–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Detroit Race for the Cure. This … [Read more…]

– Continued rapid progress with Phase 1 ELIMINATE-B trial evaluating PBGENE-HBV for Hepatitis B; Announced safety and efficacy for Cohort 1 and safety data for Cohort 2 – PBGENE-HBV demonstrated substantial antiviral activity in all Cohort 1 patients, with best responses achieving a 47-69% reduction in Hepatitis B surface antigen (HBsAg) and durable HBsAg reduction … [Read more…]

New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–#Lifesciences–ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies (“Oxford Nanopore”) (LSE: ONT), the company behind a new generation of molecular sensing technology based on nanopores, today announce the … [Read more…]

BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting … [Read more…]

Net sales increased 37% to $31.1 million Gross margin increased 480 basis points to 65.0% Net income of $3.6 million versus breakeven in prior year period Adjusted EBITDA increased by 221% to $5.0 million Raising full year 2025 revenue outlook to 22% to 27% year-over-year growth LOS ANGELES–(BUSINESS WIRE)–$NAGE #Biotech–Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced … [Read more…]

OTTAWA, Ontario–(BUSINESS WIRE)–#IDEA–BioTalent Canada has once again been named a 5-Star Diversity, Equity and Inclusion Employer by Canadian HR Reporter. This recognition underscores the organization’s leadership in fostering inclusive workplace practices and driving change across Canada’s bio-economy. Selected as one of 14 winners, BioTalent Canada stands out for embedding IDEA—Inclusion, Diversity, Equity and Accessibility— into … [Read more…]

Federal agencies and research partners can slash months from ATO timelines by procuring COTS tools to launch health research projects faster FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP®) Moderate … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August … [Read more…]